Ascendis Pharma (ASND) Q2 2026 Earnings Call Transcript
Revenue surged 105% year-over-year as three approved products scale globally.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
More in Finance & Markets
Tapestry (TPR) Q4 2026 Earnings Call Transcript
Coach drives record revenue as Tapestry hits three-year targets early.
TerraPay and Deutsche Bank expand global payment connectivity
TerraPay, a global money movement company announced a collaboration with Deutsche Bank, that will provide access to the bank's correspondent banking network, technology and product capabilities…
Philadelphia Area Manufacturing Activity Continued to Expand in August
The reserve bank’s manufacturing business outlook survey showed that the current-activity index rose to 47.4 in August from 41.4 in July.
Brookfield (BN) Q2 2026 Earnings Call Transcript
CEO Flatt discusses $210B deployable capital and AI infrastructure expansion.
Tandem Bank strengthens C-suite
Digital challenger bank Tandem has announced a series of senior leadership changes as it accelerates a new investor-backed strategy focused on sustainable finance - helping customers live more…
X-Energy (XE) Q2 2026 Earnings Call Transcript
Revenue surged 154% as federal funding and reactor orders accelerated.